Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn 4.25%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.25%
Dec 31, 2025 16.72%
Sep 30, 2025 6.26%
Jun 30, 2025 29.55%
Mar 31, 2025 1.10%
Dec 31, 2024 454.50%
Sep 30, 2024 2,346.75%
Jun 30, 2024 262.87%
Mar 31, 2024 45.34%
Dec 31, 2023 -385.09%
Sep 30, 2023 137.74%
Jun 30, 2023 -12.27%
Mar 31, 2023 -341.30%
Dec 31, 2022 -80.07%
Sep 30, 2022 -119.65%
Jun 30, 2022 -125.68%
Mar 31, 2022 -415.81%
Dec 31, 2021 -47.16%
Sep 30, 2021 -70.61%
Jun 30, 2021 -112.35%
Mar 31, 2021 -80.42%
Dec 31, 2020 86.64%
Sep 30, 2020 86.34%
Jun 30, 2020 87.89%
Mar 31, 2020 1,299.62%
Dec 31, 2019 -43.37%
Sep 30, 2019 -25.64%
Jun 30, 2019 -43.45%
Mar 31, 2019 70.81%
Dec 31, 2018 -29.34%
Sep 30, 2018 14.75%
Jun 30, 2018 165.18%
Mar 31, 2018 67.34%
Dec 31, 2017 44.33%
Sep 30, 2017 -19.13%
Jun 30, 2017 -62.59%
Mar 31, 2017 -334.59%
Dec 31, 2016 21.14%
Sep 30, 2016 -3.20%
Jun 30, 2016 160.91%
Mar 31, 2016 82.70%
Dec 31, 2015 12.32%
Sep 30, 2015 -2.80%
Jun 30, 2015 -77.17%
Mar 31, 2015 124.90%
Dec 31, 2014 0.39%
Sep 30, 2014 1.83%
Jun 30, 2014 47.18%
Mar 31, 2014 -167.84%
Dec 31, 2013 126.00%
Sep 30, 2013 67.01%
Jun 30, 2013 117.10%
Mar 31, 2013 -69.26%
Dec 31, 2012 -331.69%
Sep 30, 2012 -34.30%
Jun 30, 2012 90.10%
Mar 31, 2012 160.75%
Dec 31, 2011 100.08%
Sep 30, 2011 58.71%